A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
חו"ל (דורש נסיעה)מגייס משתתפיםPHASE1
מצבים רפואיים
Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia · Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
Contact: Principal Investigator (Shannon Maude, MD)Methodist Children's Hospital, San Antonio, Texas, United States
Contact: Principal Investigator (Amanda Lipsitt, MD)Primary Children's Hospital, Salt Lake City, Utah, United States
Contact: Principal Investigator (Michael Pulsipher, MD)Hospital Vall d'Hebron, Barcelona, Spain
Contact: Principal Investigator (Cristina Diaz de Heredia, MD)Hospital Nino Jesus, Madrid, Spain
Contact: Principal Investigator (Alba Rubio, MD)Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom
Contact: Principal Investigator (Dr Juliana Silva, MD)Royal Manchester Children's Hospital, Manchester, United Kingdom
Contact: Principal Investigator (Denise Bonney, MD)Great North Children's Hospital, Newcastle upon Tyne, United Kingdom
Contact: Principal Investigator (Geoff Shenton, MD)